ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,157,000 | +18.0% | 171,291 | -8.9% | 0.17% | -15.5% |
| Q3 2020 | $7,759,000 | -29.1% | 188,089 | -16.6% | 0.21% | -33.8% |
| Q2 2020 | $10,938,000 | -36.7% | 225,657 | -44.8% | 0.31% | -49.8% |
| Q1 2020 | $17,278,000 | +8.6% | 408,954 | +10.0% | 0.62% | +52.8% |
| Q4 2019 | $15,905,000 | +12.1% | 371,777 | -5.7% | 0.40% | +4.9% |
| Q3 2019 | $14,189,000 | -1.4% | 394,253 | -26.8% | 0.39% | +8.7% |
| Q2 2019 | $14,388,000 | -0.7% | 538,278 | -0.2% | 0.36% | -1.9% |
| Q1 2019 | $14,484,000 | +31.8% | 539,444 | -20.6% | 0.36% | +16.8% |
| Q4 2018 | $10,989,000 | -29.7% | 679,605 | -9.8% | 0.31% | -16.4% |
| Q3 2018 | $15,639,000 | – | 753,314 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |